Novel monoclonal antibody therapy shows promising results in patients with moderate to severe atopic dermatitis

Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab-;a novel, patient-tailored monoclonal antibody therapy-;showed promising results both while taking the drug and up to 20 weeks after the therapy was stopped, Mount Sinai researchers reported in The Lancet.

source https://www.news-medical.net/news/20221212/Novel-monoclonal-antibody-therapy-shows-promising-results-in-patients-with-moderate-to-severe-atopic-dermatitis.aspx

Comments

Post a Comment

Popular posts from this blog

New and surprising evidence that ChatGPT can perform several intricate tasks relevant to handling complex medical and clinical information

Researchers evaluated the performance of an AI model named ChatGPT to perform clinical reasoning on the United States Medical Licensing Exam (USMLE). source https://www.news-medical.net/news/20230213/New-and-surprising-evidence-that-ChatGPT-can-perform-several-intricate-tasks-relevant-to-handling-complex-medical-and-clinical-information.aspx
Read more

"Deep sequencing" of the genome informs diagnoses and treatment of vascular anomalies

Researchers from Children's Hospital of Philadelphia (CHOP) recently discovered that extremely thorough "deep sequencing" of the genome in tissue samples and cell-free DNA of patients with potentially life-threatening vascular anomalies captured several genetic variants related to disease that were not captured with conventional genetic sequencing methods. source https://www.news-medical.net/news/20230601/Deep-sequencing-of-the-genome-informs-diagnoses-and-treatment-of-vascular-anomalies.aspx
Read more